Navigating the Legal Landscape – The Tylenol autism lawsuit has been consolidated into an MDL class action lawsuit since 2022 and is still in progress today. However, parents of children with autism spectrum disorder (ASD) are still waiting to hear the results of this class-action suit against Johnson & Johnson (J&J).
According to ConsumerNotice, the first Tylenol Autism lawsuit was filed in June 2022, followed by 100 more plaintiffs. Here is what you need to know about the lawsuit, including how it started and where it stands today:
An Overview of Autism
Autism is a neurodevelopmental disorder that affects communication and social interaction. It can be diagnosed before age 3, but symptoms typically begin in infancy or early childhood. Per data from the Centers for Disease Control and Prevention (CDC), 1 in 36 children are diagnosed with Autism Spectrum Disorder.
ASDs are characterized by difficulties in social interaction, verbal and nonverbal communication, and repetitive behaviors or interests. Symptoms vary widely across people with ASDs. Some may have serious intellectual disabilities, while others have average or above-average intelligence.
The exact cause of autism remains unknown, but research points to genetics and environmental factors such as infections during pregnancy or preterm birth complications as possible causes for ASDs. There is no cure for this condition yet. Still, treatments available may help manage symptoms so individuals with ASD can lead more independent lives.
What Is the Tylenol Autism Lawsuit?
The Tylenol autism lawsuit is a class-action lawsuit that alleges that prenatal Tylenol exposure causes autism in children. The plaintiffs are parents who claim their children developed autism after the mothers were given Tylenol during pregnancy or shortly after giving birth.
The plaintiffs are blaming J&J through the Tylenol autism lawsuit. They say that the company failed to educate them about the potential health effects of Tylenol. The cases started after a study found that Tylenol exposure in a mother’s womb increased the risk of ASD and Attention-Deficit/Hyperactivity Disorder (ADHD).
The study’s findings published in the JAMA Network show that these exposed children were at a 20% higher risk of developing ASD and a 30% higher risk of developing ADHD.
According to TorHoerman Law, you can file a Tylenol autism lawsuit if you or a loved one gave birth to a child with ASD after consuming the acetaminophen during pregnancy. You can gather evidence to prove the connection and fight for compensation.
Allegations and Arguments in Tylenol Autism Lawsuit
Tylenol, a popular pain reliever and over-the-counter medication, is a supermarket brand that has existed since 1955. Despite its popularity, Tylenol has been the subject of many lawsuits. In fact, many people associate this product with lawsuits because they are so prevalent in our society today.
Tylenol, also known as acetaminophen or APAP, was created by McNeil Laboratories, INC, a subsidiary of J&J. The drug works by reducing inflammation caused by arthritis or injury to muscles and joints throughout your body when taken orally every four hours for up to six days consecutively at 250mg per dose during every 24 hours.
However, some side effects are associated with using too much acetaminophen, including nausea/vomiting, stomach pain, diarrhea, etc. Studies have found that if pregnant women consume this drug, it can lead to a higher chance of giving birth to children with ASD. In fact, acetaminophen, the core ingredient of Tylenol, is responsible for 56,000 emergency department visits in the US.
Time and again, many studies have proven the link between Tylenol or acetaminophen with neurological disorders. These studies are at the core of the allegations against J&J in the Tylenol autism lawsuit. For instance, a recent study published in the PLOS One Journal shows that children exposed to this drug during prenatal or infancy score significantly higher on 3 out of 7 child behavior checklist syndrome scales.
However, the Tylenol autism lawsuit is still in its early stages. As of this writing, it’s unclear whether the plaintiffs can prove that Tylenol caused or contributed to their children’s autism. If they do, however, it could have wide-reaching effects on future cases involving alleged product liability issues and ASD.
How to Increase Your Chances of Winning a Tylenol Autism Lawsuit
Here are some tips to increase your chances of winning the Tylenol Autism Lawsuit:
- Be a member of the class. To be eligible for compensation, you must be one of the millions who took acetaminophen during pregnancy between 1982 and 2013 and experienced harm related to ASD.
- Prove that you or your child were harmed by taking acetaminophen during pregnancy. The claimants’ attorneys will need evidence showing that their clients were either diagnosed with ASD after taking Tylenol or experienced some other adverse side effects from taking it during pregnancy, such as miscarriage or stillbirth, which led them down an irreversible path toward developing an ASD diagnosis later in life.
There are many ways plaintiffs can provide evidence showing they were affected by acetaminophen use while pregnant, medical records detailing the symptoms they experienced, witness testimony from family members who saw firsthand how these symptoms affected their loved ones, etc.
What Is the Settlement Amount for the Tylenol Autism Lawsuit?
The Tylenol autism lawsuit settlement amount can vary widely. There is no specific amount decided yet. However, if you can establish the link between Tylenol and your child having ASD, you can expect a settlement amount of between $50,000 and $300,000, or even more.
There are a lot of different answers to this question depending on who you ask and when they answered it. In fact, there may never be one definitive answer because there are so many variables involved in determining what money should go where in any lawsuit settlement like this one.
The Tylenol autism lawsuit is a complicated case with many moving parts. The plaintiffs in the case have suffered from the effects of taking their children’s medication and are seeking compensation for their losses. However, pharmaceutical companies Bayer and Johnson & Johnson have disputed these claims, saying there is no link between acetaminophen use and ASD.
This article provided some background information on both sides of this dispute so that readers can better understand what they’re looking at when they read more about it in other sources or hear about it on TV news shows.